Skip to content

Comparison effect of flaxseed dietary and supplementary of omega-3fatty acid on cyclical mastalgia intensity among referring women to hospitals of Shiraz university of medical sciences 2012-2013

Comparison effect of flaxseed dietary and supplementary of omega-3fatty acid on cyclical mastalgia intensity among referring women to hospitals of Shiraz university of medical sciences 2012-2013

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013010510327N3
Enrollment
180
Registered
2013-07-01
Start date
2013-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastalgia. Mastodynia

Interventions

Intervention 1: first interventional group: the group will receive Dietary flaxseed breads. This intervention continue for two menstrual cycles. Intervention 2: second interventional group: the group
Treatment - Other
Treatment - Drugs
Placebo
first interventional group: the group will receive Dietary flaxseed breads. This intervention continue for two menstrual cycles
second interventional group: the group will recive omega3 for 2 menstrual cycles
control group: this group will recived wheat bread for two menstrual cycles

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with cyclic mastalgia; regular menstrual cycles between 24-35 days; 4 or more mastalgia pain with VAS scale; age between 20-40 years old; not breast feeding; not to get pregnant; BMI between 19 to 29; no premature menopause; no history of breast and endometrial cancer or ovarian cancer; non family history of breast cancer; no use of pharmaceutical and plant treatment during the study and no systemic disease or history of disease. Exclusion criteria: pregnancy; starts taking any medication during the study and sensitivity or intolerance to supplements.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: First, second and third months. Method of measurement: visoual analogue scale.

Secondary

MeasureTime frame
Pain duration. Timepoint: First, second and third months. Method of measurement: Interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVaziri Farideh

Fatemeh (PBUH) College of Nursing and Midwifery, Shiraz

vazirif@sums.ac.ir+98 71 1647 4253

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026